CTN Bulletin logo
January 4, 2018  

2017 Monitoring the Future Teen Drug Use Survey Results



The National Institute on Drug Abuse (NIDA) hosted a press teleconference on December 14, 2017, to discuss the findings of the 43rd annual Monitoring the Future (MTF) survey. This year’s MTF survey of drug use and attitudes among American 8th, 10th, and 12th graders in schools nationwide continues to provide encouraging news with self-reported use of alcohol, cigarettes and many illicit drugs remaining at historically low levels. However, the survey also found that both vaping and marijuana are more popular than cigarettes. And what teens say is in the vaping device varies from nicotine, marijuana or "just flavoring." The survey also shows continuing decreases in the perceived harms of many drugs, including marijuana.

WATCH NIDA Director Dr. Nora Volkow discuss the 2017 findings.

NIDA prepared a series of infographics about the 2017 MTF survey findings that you can download here for websites and social media.

The MTF survey, funded by NIDA, is conducted by researchers at the University of Michigan at Ann Arbor. For more on the 2017 MTF survey go to: https://www.drugabuse.gov/related-topics/trends-statistics/monitoring-future


CTN Trial Progress

GraphStudy results for Open Studies as of the January 2 trial Progress Report.

CTN-0064 - Linkage to HCV Care. Enrolled 113

CTN-0068 - ADAPT-2 for Methamphetamine Use Disorder. Enrolled 112

CTN-0069 - OUD in the Emergency Department. Enrolled 94

CTN-0073 - Detecting Cocaine Use Using Smartwatches. Enrolled 11

Total Enrolled in all Studies: 24,436

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Upcoming Trainings and Events

Free E-Learning Course: Phase 3 Studies and Regulatory Review

This free, self-paced, 1-hour online training from the NIDA Clinical Trials Network will review clinical study activities that occur during Phase 3 studies, as well as the regulatory requirements for and components of an application for marketing approval in the U.S. and the E.U. CEU are available! Find out more here. . .

Free E-Learning Course: Increase Your Effectiveness in Delivering and Understanding Informed Consent in Clinical Trials

This self-paced, on-demand training is being offered on a first-come-first-served basis to research staff affiliated with the CTN. Learn the proper methods of communicating with and gaining consent from various populations of potential study subjects as well as the proper use of consent, its benefits, and concerns with its use. You'll also learn how to identify common problems with consent forms and how to select the correct form based on the characteristics of the study. This online course takes about 3.5 hours to complete and may be offered for a limited time. Find out more here. . .

2018 mHealth Training Institute - Apply Now!

Applications for the 2018 mHealth Training Institute or mHTI (July 29-August 3, 2018 at the University of California, Los Angeles) are now being accepted. Applications must be received by January 27, 2018, with notifications of acceptance sent out on April 15.

Building on the success of past mHTIs, the week-long immersion program uses a blended learning environment to provide selected scholars with a core grounding in latest mHealth methodologies and develops their capacity to successfully contribute to team science. Through reflective and active learning guided by faculty mentors, scholars will apply the gained knowledge to developing transdisciplinary mHealth solutions for real-world health problems, while building an interdisciplinary learning community and a dense scientific network. Find out more here. . .

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

News from the Nodes

Western States

Western States Node Director Dennis McCarty participated in a panel discussion addressing opioid use disorders at the OHSU Annual Illuminate Lunch on November 8, 2017.

Honora Englander, MD (Director of the OHSU IMPACT (Improving Addiction Care Team) and Alisah Moreland-Capuia, MD (Executive Director of the Avel Gordly Center for Healing - OHSU’s Community Mental Health Center) discussed their work to improve care for patients with opioid use disorder. Dennis described the CTN research on opioid use disorder and its contributions to evidence-based care. The panel was moderated by Dwight Holton, former U.S. attorney for Oregon.

OHSU hosts the Illuminate Lunch to inform community leaders about OHSU and its contributions to health, science and education. More than 300 individuals attended this year.
(Left to right) Honora Englander, MD, Dennis McCarty, PhD, Alisha Moreland-Capuia, MD, and moderator Dwight Holton, JD. (Photo by OHSU/Kristyna Wentz-Graff)

Read more about the Illuminate Lunch event, and view a 49-minute video of the opioid panel conversation at: https://echo360.org/media/0a715acb-8918-4a6a-a371-43b7713730b8/public


New from the ATTC

The Messenger, December 2017: Read about what happened at this year's Addiction Health Services Research Conference, 2017, find updates on trainings and events in the ATTC, and read about the Knowledge Network, SAMHSA's premier library of behavioral health training, technical assistance, collaboration, and workforce resources.

ATTC/NIATx Service Improvement Blog:

Northeast Node

In November, Northeast Node partner Catholic Medical Center(CMC) hosted its third annual Summit on Treating Opiate-Dependent Patients.

The annual Summit brings together physicians, dentists, podiatrists, nurse practitioners, physician assistants, other prescribers, nurses, social workers, allied health professionals, pharmacists, social service agencies, law enforcement, first responders and other stakeholders to discuss New Hampshire’s opioid epidemic.

This year’s event featured presentations by Northeast Node Director Dr. Lisa Marsch; New Hampshire Medical Examiner Dr. Kim Fallon; and Node partners from CMC, Dr. Jonathan Eddinger; Dartmouth-Hitchcock Medical Center (DHMC), Dr. Richard Barth; and Concord Hospital, Dr. Molly Rossignol.

  • Dr. Marsch presented final outcomes from the Node’s New Hampshire HotSpot study. You can read more about the HotSpot study here.
  • Dr. Fallon, the state’s Chief Medical Examiner, presented information on the opioid-related deaths that her office has handled during this year. Of the opioid-related overdose deaths processed thus far in 2017, 46% have been from fentanyl alone.
  • Dr. Eddinger, a cardiac surgeon at CMC in Manchester, NH, presented on intravenous drug use-associated endocarditis.
  • Dr. Barth, the Chief of General Surgery at DHMC in Lebanon, NH, presented results from three studies conducted at the state’s largest hospital investigating post-operative opioid prescribing for acute pain. Several novel opioid prescribing practices evaluated in these studies were shown to reduce the number of prescribed opioid pills after the five most common outpatient procedures by 53%, while still controlling post-operative pain.
  • Dr. Rossignol, an addiction specialist at Concord Hospital in Concord, NH, presented on how her practice "bridges the gap" between inpatient treatment and referral to partner organizations.

The Northeast Node was pleased to participate in Catholic Medical Center’s third annual Opiate Summit. Catholic Medical Center is a study site for CTN-0079, ED Connection to Care with Buprenorphine in Rural and Urban Settings, led by the Greater New York Node and supported by the Northeast Node.

You can stay updated on upcoming events within the Northeast Node by visiting its website, Twitter feed, and Facebook page.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

New in the CTN Dissemination Library

Assessment of the Relationship Between a Written Measure of Empathy and an Independently Rated Interview of Motivational Interviewing. Smith JL, et al. Journal of Substance Abuse Treatment 2017 (in press).

Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. Gryczynski J, et al. Journal of General Internal Medicine 2017;32(9):990-996.

Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-Delivered Intervention for Substance Use Disorders. Aharonovich E, et al. Journal of Addiction Medicine 2017 (in press).

Frequency of Cannabis Use among Primary Care Patients in Washington State. Lapham GT, et al. Journal of the American Board of Family Medicine 2017;30(6):795-805.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

PCORI Updating Addressing Disparities Priority Research Areas of Interest

The Patient-Centered Outcomes Research Institute (PCORI) will be updating the Addressing Disparities Priority Area Research Areas of Interest, with a focus on the following topics:

  • Diagnosis, Initiation of Treatment, and Retention of African Americans and Hispanics/Latinos along the HIV Care Continuum
  • Interventions to Reduce Disparities in Obstructive Sleep Apnea and Insomnia

The funding announcement will be released on January 16, 2018. Register for their upcoming Town Hall here.

Upcoming CTN Webinars

Developing and Negotiating Study Budgets and Contracts - February 8, 2018, 12-3pm.

Developing Clinical Study Budgets for Sponsors - March 16, 2018, 1-3pm.

For Clinical Trial Investigators:
Principal Investigator Oversight & Appropriate Task Delegation - March 15, 2018, 11am-12:30pm.

Email CTNtraining@emmes.com to register!



Published by the CTN Dissemination Library of the Pacific Northwest Node
Alcohol & Drug Abuse Institute, University of Washington

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol & Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

Unsubscribe | Subscribe

Copyright (C) 2016 Alcohol and Drug Abuse Institute. All rights reserved.